These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10030268)

  • 1. p53 function influences the effect of fractionated radiotherapy on glioblastoma tumors.
    Haas-Kogan DA; Kogan SS; Yount G; Hsu J; Haas M; Deen DF; Israel MA
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):399-403. PubMed ID: 10030268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma.
    Haas-Kogan DA; Yount G; Haas M; Levi D; Kogan SS; Hu L; Vidair C; Deen DF; Dewey WC; Israel MA
    Int J Radiat Oncol Biol Phys; 1996 Aug; 36(1):95-103. PubMed ID: 8823264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53-independent apoptosis: a mechanism of radiation-induced cell death of glioblastoma cells.
    Haas-Kogan DA; Dazin P; Hu L; Deen DF; Israel A
    Cancer J Sci Am; 1996; 2(2):114-21. PubMed ID: 9166509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fractionated radiotherapy is the main stimulus for the induction of cell death and of Hsp70 release of p53 mutated glioblastoma cell lines.
    Rubner Y; Muth C; Strnad A; Derer A; Sieber R; Buslei R; Frey B; Fietkau R; Gaipl US
    Radiat Oncol; 2014 Mar; 9(1):89. PubMed ID: 24678590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of radiosensitivity of wild-type p53 human glioma cells by adenovirus-mediated delivery of the p53 gene.
    Lang FF; Yung WK; Raju U; Libunao F; Terry NH; Tofilon PJ
    J Neurosurg; 1998 Jul; 89(1):125-32. PubMed ID: 9647183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells.
    Quick QA; Gewirtz DA
    J Neurosurg; 2006 Jul; 105(1):111-8. PubMed ID: 16871885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Functional restoration of tumor suppressor p53 alters susceptibility of glioblastoma cells to irradiation--analysis using a cell line containing a temperature-sensitive mutant].
    Tsuchiya K
    Hokkaido Igaku Zasshi; 2000 Jul; 75(4):265-74. PubMed ID: 10976406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation of TRADD mediates p53-independent radiation-induced apoptosis of glioma cells.
    Yount GL; Afshar G; Ries S; Korn M; Shalev N; Basila D; McCormick F; Haas-Kogan DA
    Oncogene; 2001 May; 20(22):2826-35. PubMed ID: 11420694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration.
    Antipas VP; Stamatakos GS; Uzunoglu NK; Dionysiou DD; Dale RG
    Phys Med Biol; 2004 Apr; 49(8):1485-504. PubMed ID: 15152687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
    Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
    Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential radiosensitizing potential of temozolomide in MGMT promoter methylated glioblastoma multiforme cell lines.
    van Nifterik KA; van den Berg J; Stalpers LJ; Lafleur MV; Leenstra S; Slotman BJ; Hulsebos TJ; Sminia P
    Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1246-53. PubMed ID: 17967314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme.
    Prados MD; Wara WM; Sneed PK; McDermott M; Chang SM; Rabbitt J; Page M; Malec M; Davis RL; Gutin PH; Lamborn K; Wilson CB; Phillips TL; Larson DA
    Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):71-7. PubMed ID: 11163499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle synchrony unmasks the influence of p53 function on radiosensitivity of human glioblastoma cells.
    Yount GL; Haas-Kogan DA; Vidair CA; Haas M; Dewey WC; Israel MA
    Cancer Res; 1996 Feb; 56(3):500-6. PubMed ID: 8564961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced radiosensitivity of malignant glioma cells after adenoviral p53 transduction.
    Broaddus WC; Liu Y; Steele LL; Gillies GT; Lin PS; Loudon WG; Valerie K; Schmidt-Ullrich RK; Fillmore HL
    J Neurosurg; 1999 Dec; 91(6):997-1004. PubMed ID: 10584846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic damage and the radiation-induced G1-phase checkpoint.
    Gupta N; Vij R; Haas-Kogan DA; Israel MA; Deen DF; Morgan WF
    Radiat Res; 1996 Mar; 145(3):289-98. PubMed ID: 8927696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial cells co-cultured with wild-type and dominant/negative p53-transfected glioblastoma cells exhibit differential sensitivity to radiation-induced apoptosis.
    Khodarev NN; Labay E; Darga T; Yu J; Mauceri H; Gupta N; Kataoka Y; Weichselbaum RR
    Int J Cancer; 2004 Mar; 109(2):214-9. PubMed ID: 14750172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR overexpression and radiation response in glioblastoma multiforme.
    Barker FG; Simmons ML; Chang SM; Prados MD; Larson DA; Sneed PK; Wara WM; Berger MS; Chen P; Israel MA; Aldape KD
    Int J Radiat Oncol Biol Phys; 2001 Oct; 51(2):410-8. PubMed ID: 11567815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of radiation-induced G2 delay potentiates cell death by apoptosis and/or the induction of giant cells in colorectal tumor cells with disrupted p53 function.
    Bracey TS; Williams AC; Paraskeva C
    Clin Cancer Res; 1997 Aug; 3(8):1371-81. PubMed ID: 9815821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined radiation and p53 gene therapy of malignant glioma cells.
    Badie B; Goh CS; Klaver J; Herweijer H; Boothman DA
    Cancer Gene Ther; 1999; 6(2):155-62. PubMed ID: 10195882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of p53 and p21 in primary glioblastomas.
    Gross MW; Kraus A; Nashwan K; Mennel HD; Engenhart-Cabillic R; Schlegel J
    Strahlenther Onkol; 2005 Mar; 181(3):164-71. PubMed ID: 15756520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.